EnteroMedics launches obesity device in U.S.; Breast implant maker sets terms for $75M IPO;

@FierceMedDev: ICYMI: Oxford Performance Materials gets FDA nod for 3-D printed spinal implant. Report | Follow @FierceMedDev

@EmilyWFierce: ICYMI from FiercePharma: Shire CEO: We're prepared to wait for the right deal. Article | Follow @EmilyWFierce

> EnteroMedics ($ETRM) has launched its vBloc Access device that offers neurostimulation to treat obesity and metabolic diseases. Its shares are up 8% on the news. More

> Medtronic ($MDT) will face a patent infringement lawsuit from a Nevada doctor over three patents for a device to treat scoliosis. More

> eDublin, Ireland-based breast implant maker GC Aesthetics has set terms to for a $75 million IPO by selling 5.4 million shares at a range of $13 to $15 each. More

Biotech News

@FierceBiotech: Allergan bags NMDA depression drugs in $560M-plus Naurex buyout. News | Follow @FierceBiotech

@JohnCFierce: The China stock landslide is back on. More from Reuters | Follow @JohnCFierce

@DamianFierce: I kinda forgot this hadn't already happened, tbh. Aegerion release/Article | Follow @DamianFierce

> Nymox soars after claims of a post-PhIII BPH turnaround. News

> Eli Lilly soldiers on in big PhIII evacetrapib study. Item

> Allergan joins the hunt for a 'transformational' biotech deal. Editor's corner

Pharma News

@FiercePharma: Harvard scientists link pesticides with bee losses. More from FierceAnimalHealth | Follow @FiercePharma

@EricPFierce: Lupin lands its first US manufacturing site with $880M deal for GAVIS, 6-year-old NJ firm. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: ICYMI Friday: UnitedHealth uses newfound scale to negotiate pay-for-performance deals. Article | Follow @CarlyHFierce

> Amgen wins new myeloma nod for blockbuster hopeful Kyprolis. News

> AstraZeneca snags $300M from Sanofi for rare cancer med amid cash-generating deal spree. Story

> Forget Mylan: Teva inks $40B-plus pact for Allergan's generics biz. Article

Animal Health News

> Animal health drives double-digit growth at Abaxis. Report

> Harvard scientists link pesticides with bee losses. Item

> H.J. Baker breaks ground on multimillion-dollar facility near KC animal health corridor. More

> USDA speeds development of bird flu vaccine as fears of revived virus mount. Article

> Aratana predicts full launch of two lymphoma drugs for dogs in late 2016. Story

Biotech IT News

> SynBio startup Ginkgo Bioworks lands $45M to fuel push into pharma. More

> PCORI board signs off on $142.5M investment to scale up health data network. Story

> BGI CEO steps down to escalate interest in artificial intelligence. Article

> Deep Genomics sets up shop to marry deep learning and genomics. Item

> Oxford Nanopore raises $109M ahead of key period for its sequencing technology. Report

Pharma Marketing News

> Sanofi draws a $14,600 line in the sand for Praluent payer fight. Report

> Spotlight-savvy Kim Kardashian adds Duchesnay med to her talking points. Story

> Will marketing make the difference in approval of Sprout's 'pink pill' for women? News

> J&J's Stelara may be under fire in psoriasis, but it's positioned to score elsewhere. More

> I'll prescribe it if you do: Prescribers susceptible to peer pressure, study finds. Report

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.